Joel Habener is a Professor of Medicine at Harvard Medical School.

Habener worked with Svetlana Mojsov on elucidating the role of incretin hormones such as Glucagon-like peptide-1 (GLP-1) and Glucagon-like peptide-2 (GLP-2). Habener received credit for the work on hormones when Mosjov was not credited.^[1] Habener was awarded the 2020 Warren Alpert Foundation Prize along with Daniel Drucker and Jens Juul Holst.^[2] He was elected to the National Academy of Sciences in 2020.^[3] In 2021 he was awarded the Canada Gairdner International Award.^[4] In 2023, he received the VinFuture Prize.^[5] In 2024, he was awarded the Princess of Asturias Awards for Technical and Scientific Research.^[6] and also in 2024 the Tang Prize in the category of "Biopharmaceutical Science".^[7]